Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T08:35:43.389Z Has data issue: false hasContentIssue false
  • English
  • Français

Alprazolam and panic disorder

Published online by Cambridge University Press:  02 January 2018

David Healy
David Healy*
Affiliation:
Academic Sub-Department of Psychological Medicine North Wales Hospital Denbigh, Clwyd LL16 5SS
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In May 1988, the greater part of an issue of Archives of General Psychiatry was given over to reports of the results of a clinical trial of alprazolam for panic disorder. More recently, in March 1991, supplement no 365, of Acta Psychiatrica Scandinavica (APS) was devoted to a further trial of alprazolam for panic disorder. Few other psychotropic compounds have received such concentrated coverage. What, if anything, emerges from the studies reported?

Type
Expert opinion
Information
Psychiatric Bulletin , Volume 15 , Issue 11 , November 1991 , pp. 682 - 683
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1991

References

Acta Psychiatrica Scandinavica (1991) 83, Supp. No. 365.Google Scholar
Archives of General Psychiatry (1988) 45, 407–450.Google Scholar
Marks, I. M., De Albuquerque, A., Cotteaux, J. et al (1989) Archives of General Psychiatry, 46, 668–670.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.